FDA approves Asmanex for once-daily treatment of asthma
The FDA ( Food and Drug Administration ) has approved the use of Asmanex Twisthaler 220 mcg ( Mometasone ...
Leggi articolo
Low-dose Aspirin for prevention of stroke in women
A study performed at Harvard Medical School found that low-dose Aspirin may reduce the risk of ischemic stroke in women.
Previous ...
Leggi articolo
Depo-subQ Provera 104 ( Medroxyprogesterone ) for endometriosis pain
The FDA ( Food and Drug Administration ) approved Depo-subQ Provera 104 ( Medroxyprogesterone ) for the management of pain ...
Leggi articolo
Intracranial stenosis, Aspirin is safer than Warfarin for stroke prevention
A randomized trial showed that Aspirin is safer than Warfarin for stroke prevention in patients with intracranial arterial stenosis.
Intracranial stenosis ...
Leggi articolo
Chronic hepatitis B, FDA approves Entecavir
The FDA ( Food and Drug Administration ) approved Baraclude ( Entecavir ) tablets and oral solution for the treatment ...
Leggi articolo
Viagra may cause ischemic optic neuropathy
Researchers from the University of Minnesota in Minneapolis, reported seven patients who developed nonarteritic anterior ischemic optic neuropathy ( NAION ...
Leggi articolo
Lung cancer, positive preliminary data for ProMune
ProMune is a synthetic agonist for Toll-like receptor 9 ( TLR9 ).
By stimulating TLR9, ProMune acts directly and selectively on ...
Leggi articolo
Folate intake associated with hypertension in women
Higher total folate intake is associated with a decreased risk of hypertension, particularly in younger women.
Researchers at Harvard Medical School ...
Leggi articolo
Bortezomib approved for second-line multiple myeloma
The U.S. FDA ( Food and Drug Administration ) approved a supplemental New Drug Application ( sNDA ) for Velcade ...
Leggi articolo
Abbott, ADHD drug is being discontinued
Abbott’s Cylert ( Pemoline ) is a central nervous system stimulant indicated for the treatment of attention deficit hyperactivity disorder ...
Leggi articolo
Osteoporosis, FDA approves once-monthly Ibandronate
The U.S. FDA ( Food and Drug Administration ) approved once- monthly oral Ibandronate ( Boniva ) 150 mg tablets, ...
Leggi articolo
Finasteride may prevent prostate cancer
Finasteride ( Proscar ) blocks an enzyme called 5-alpha-reductase, which is necessary to change testosterone to another hormone that causes ...
Leggi articolo
Obstructive sleep apnea and risk of sudden death from cardiac causes
The risk of sudden death from cardiac causes is highest between the hours of 6 a.m. and noon and ...
Leggi articolo
Coronary heart disease, high-versus low dose Atorvastatin
The Third Report of the National Cholesterol Education Program ( NCEP ) - Adult Treatment Panel and the most recent ...
Leggi articolo
Public Citizen petitions FDA to withdraw Abbott’s Cylert
Public Citizen, a U.S. consumer organization, petitioned the U.S. Food and Drug Administration (FDA) to immediately remove Pemoline ...
Leggi articolo
Epilepsy drug Valproate during pregnancy may increase the risk of severe birth defects
Valproate ( Valproic Acid ), an epilepsy drug, is indicated as monotherapy and adjunctive therapy in complex partial seizures in ...
Leggi articolo
Nesiritide increases the risk of worsening renal function in patients with ADHF
In 2001, Nesiritide ( Natrecor ) has been approved by the FDA for the intravenous treatment of patients with acutely ...
Leggi articolo
Avonex associated with cases of severe liver damage
Avonex, Interferon beta-1a, is approved for the treatment of patients with relapsing forms of multiple sclerosis to slow the accumulation ...
Leggi articolo
New warning for Xigris, a sepsis drug
Xigris has received FDA approval for increasing survival in high-risk adult patients with severe sepsis.
Xigris ( Drotrecogin alfa, activated ...
Leggi articolo
Role of anti-hepatitis C virus treatment in patients with B-cell non-Hodgkin's lymphoma and HCV infection
Hepatitis C virus ( HCV ) plays a role in the development of both hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma ...
Leggi articolo
Cholesterol affects tumor survival
Lipid rafts are cholesterol- and sphingolipid-enriched microdomains in cell membranes that regulate phosphorylation cascades originating from membrane-bound proteins.
They are dynamic ...
Leggi articolo
Smoking may be a risk factor for progression of multiple sclerosis
An increased risk of multiple sclerosis among smokers has been found in several prospective epidemiological studies.
Investigators from Harvard School of ...
Leggi articolo
BNP is a strong prognostic indicator in patients with heart failure
The clinical assessment of heart failure is difficult; it is difficult to determine which patients have heart failure and, once ...
Leggi articolo
FDA approves Symlin, new diabetes drug
The FDA ( Food and Drug Administration ) approved Symlin, an injectable drug to control blood sugar for adults ...
Leggi articolo
Parecoxib and Valdecoxib, increased cardiovascular events after CABG
A study, led by Nancy A. Nussmeier at the Texas Heart Institute, St. Luke's Episcopal Hospital, in Houston, assessed the ...
Leggi articolo
Aliskiren, a novel renin inhibitor in hypertension
Aliskiren ( SPP100 ) is the first in the new class of antihypertensive agents, called renin inhibitors.
Suppression of the renin ...
Leggi articolo
FDA approves Temodar as treatment for glioblastoma multiforme
The FDA ( Food and Drug Administration ) has approved a new indication for Temozolomide ( Temodar ), ...
Leggi articolo
Vitamin E can increase the risk for heart failure
A study has shown that in patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent ...
Leggi articolo
Lung cancer, Avastin extends survival
An interim analysis of a Phase III study of Avastin ( Bevacizumab ) in combination with Paclitaxel and Carboplatin ...
Leggi articolo
Autoantibody formation in patients with rheumatoid arthritis treated with Infliximab
Long-term use of anti-TNF-alpha agents can lead to the development of autoantibodies.
Infliximab ( Remicade ) is a chimeric human-murine monoclonal ...
Leggi articolo
Rasagiline as an adjunct to Levodopa in patients with Parkinson's disease and motor fluctuations
Management of patients with complications of Parkinson's disease remains a challenge for both the clinician and the patient.
These complications ...
Leggi articolo
Risk factors for preeclampsia
Preeclampsia, a major cause of maternal and fetal mortality and morbidity, is characterized by development of swelling, elevated blood pressure ...
Leggi articolo
Aripiprazole for maintaining efficacy in bipolar I disorder
The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with ...
Leggi articolo
Two atopic dermatitis drugs should be used cautiously
The U.S. FDA ( Food and Drug Administration ) advised health care professionals to prescribe Elidel ( Pimecrolimus ) ...
Leggi articolo
Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin’s lymphoma
A phase II trial, led by John D. Hainsworth of the Sarah Cannon Cancer Center and Tennessee Oncology, Nashville ...
Leggi articolo
Bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma
A phase II study, led by Andre Goy, of the University of Texas M.D. Anderson Cancer Center, Houston, evaluated efficacy ...
Leggi articolo
Non-diabetic proteinuric nephropathies, add-on therapy provides no benefit
In chronic nephropathies, ACE inhibitors have renoprotective effect.
REIN-2 Study Group assessed the effect of intensified versus conventional blood-pressure control on ...
Leggi articolo
Addition of Clopidogrel to Aspirin and fibrinolytic therapy proves beneficial for myocardial infarction
Patients whose occluded arteries were treated with standard fibrinolytic regimen , including Aspirin, following acute myocardial infarction with ST-segment elevation ...
Leggi articolo
Celecoxib inhibits prostate cancer growth
Selective cyclooxygenase-2 ( COX-2 ) inhibitors may suppress carcinogenesis by both COX-2-dependent and COX-2-independent mechanisms.
Researchers at the Weill Medical College ...
Leggi articolo
ADRAC : bisphosphonates and osteonecrosis of the jaw
Bisphosphonates are drugs commonly used to prevent and treat osteoporosis in post-menopausal women.
They are widely used in the management ...
Leggi articolo
APC study, cardiovascular risk associated with Celecoxib
Adenoma Prevention with Celecoxib ( APC ) study investigators reviewed all potentially serious cardiovascular events among 2035 patients with a ...
Leggi articolo
Efficacy of Lenalidomide in relapsed or refractory multiple myeloma
The IDMC ( Independent Data Monitoring Committee ) found a statistically significant improvement in time to disease progression in patients ...
Leggi articolo
WHO: public health concern on acrylamide in food
In 2002, Swedish studies showed for the first time the unintentional formation of relatively high levels of acrylamide during the ...
Leggi articolo
Genetic variants in UBQLN1 increase the risk of Alzheimer’s disease
Researchers from the MassGeneral Institute for Neurodegenerative Disorders ( MIND ) in Charlestown have identified a gene variant that may ...
Leggi articolo
Diabetes increases liver cancer risk
A study, carried out by investigators at Houston Veterans Affairs Medical Center, examined the association between diabetes and increased ...
Leggi articolo
Alzheimer’s disease could be a neuroendocrine disorder
The accumulating evidence that reduced glucose utilization and deficient energy metabolism occur early in the course of disease, suggests a ...
Leggi articolo
FDA has approved Pegasys and Copegus for the treatment of chronic hepatitis C in HIV patients
FDA ( Food and Drug Administration ) has approved Pegasys ( Peginterferon alfa-2a ) and Copegus ( Ribavirin ) for ...
Leggi articolo
Thalidomide attenuates weight loss and wasting in pancreatic cancer
Thalidomide was first marketed in Europe in the late 1950's. It was used as a sleeping pill and to ...
Leggi articolo
European Union, Pegasys approved for the treatment of chronic hepatitis B
European Commission has approved Pegasys ( Peginterferon alfa-2a ) for the treatment of chronic hepatitis B.
The approval is granted ...
Leggi articolo
Low-dose Aspirin prevents strokes in women
The Women's Health Study ( WHS ) is a randomized, double-blind, placebo-controlled trial evaluating the balance of benefits and risks ...
Leggi articolo
Peginterferon alfa-2a plus Ribavirin for chronic hepatitis C virus infection in HIV-infected patients
The final statement from the 1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV ...
Leggi articolo
Drug-eluting stent: Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis
The REALITY Trial is a prospective, randomized study involving 1,386 patients at 90 hospitals centers in Europe, Latin America and ...
Leggi articolo
Recombinant activated factor VII in acute intracerebral haemorrhage
The New England Journal of Medicine ( NEJM ) reports positive results from the clinical trial of recombinant activated factor ...
Leggi articolo
FDA has approved Candesartan Cilexetil for the treatment of heart failure
AstraZeneca announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Candesartan Cilexetil ( ...
Leggi articolo
Treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg is supported by strong evidence
A review of the medical literature suggests that older persons with systolic hypertension (and systolic blood pressure of at least ...
Leggi articolo
A to Z Trial , Z phase : Simvastatin did not achieve the prespecified end point
The Aggrastat to Zocor study, or A to Z study, phase Z has assessed whether early intensive Simvastatin treatment ...
Leggi articolo
ACTION trial : addition of Nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival
Calcium antagonists such as Nifedipine are used to relieve the symptoms of angina, but there have been doubts about their ...
Leggi articolo
Alzheimer’s drugs, NICE proposes to withdraw from NHS
The drugs Donepezil ( Aricept ), Rivastigmine ( Exelon ), Galantamine ( Remynil ), and Memantine ( Ebixa ) should ...
Leggi articolo
Therapeutic vaccine shows promise in men with prostate cancer
Telomerase reverse transcriptase ( hTERT ) represents an attractive target for cancer immunotherapy because hTERT is reactivated in most human ...
Leggi articolo
Prostate cancer, vitamin E could cut the risk
The ATBC ( Alpha-Tocopherol, Beta-Carotene Cancer Prevention ) study investigated risk factors and prevention of major chronic diseases, such as ...
Leggi articolo
Dietary fiber intake reduces blood pressure in patients with hypertension
People who ate 7.2 to 18.9 grams of fiber a day experienced a reduction in both systolic and diastolic blood ...
Leggi articolo
FDA: Crestor, favorable risk/benefit ratio
The Food and Drug Administration ( FDA ) issued a public health advisory, a patient information sheet and a corresponding ...
Leggi articolo
Use of Cannabis may lead to psychotic symptoms
New research appearing in the journal Addiction supports the growing evidence that Cannabis can seriously damage mental health.
Cannabis is thought ...
Leggi articolo
Folate and vitamin B12 can reduce the risk of hip fracture in elderly patients following a stroke
Hyperhomocysteinemia is a risk factor for both ischemic stroke and osteoporotic fractures in elderly men and women.
Folate and vitamin ...
Leggi articolo
Multiple Sclerosis, Tysabri withdrawn from market
The Food and Drug Administration ( FDA ) issued a public health advisory to inform patients and health care providers ...
Leggi articolo
Guidelines on use of Antiretroviral Drugs to prevent HIV infection after sexual, drug use, and accidental exposure
CDC ( Centers for Disease Control and Prevention ) has announced new guidelines for the use of antiretroviral drugs to ...
Leggi articolo
Linezolid and neuropathy
Linezolid ( Zyvoxam ), a synthetic antibacterial agent in a new class of antibiotics, the oxazolidinones, has been marketed in ...
Leggi articolo
Reports of lymphoma and skin cancer in patients treated with Elidel cream
FDA is investigating postmarketing reports of lymphoma and skin cancer in children and adults treated with Elidel ( Pimecrolimus ), ...
Leggi articolo
EMEA, regulatory actions for the COX-2 inhibitor
The European Medicines Agency has announced a number of regulatory actions for the COX-2 inhibitor class of medicines following discussions ...
Leggi articolo
New Warning on Depo-Provera Contraceptive Injection
The FDA announced that a new black-box warning has been added to the labeling for Depo-Provera Contraceptive Injection. The ...
Leggi articolo
NCI has stopped a clinical trial of the Cox-2 Inhibitor Celebrex
The FDA released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex ( celecoxib ...
Leggi articolo
Bextra, boxed warning concerning severe skin reactions and warning regarding cardiovascular risk
FDA announced important new information on side effects associated with the use of Bextra, a COX-2 selective non-steroidal anti-inflammatory ...
Leggi articolo
Warning on lymphoma risk with TNF blockers
The manufacturers of the drugs Humira ( adalibumab ), Remicade ( infliximab ) and Enbrel ( etanercept ) have added ...
Leggi articolo
Treatment for patients with the metabolic syndrome
A study presented at the 40th Annual Meeting of the European Association for the Study of Diabetes ( EASD ), ...
Leggi articolo
Vioxx, increased risk of heart attack and stroke
Merck is withdrawing Vioxx ( Rofecoxib ) from the market after the data safety monitoring board overseeing a long-term study ...
Leggi articolo
Potential adverse effects of SSRIs and other anti-depressants on newborns
Newborns may be adversely affected when pregnant women take Selective Serotonin Re-uptake Inhibitors ( SSRIs ) and other newer anti-depressants ...
Leggi articolo
Valdecoxib, severe cutaneous reactions
Valdecoxib ( Bextra ), a selective inhibitor of cyclo-oxygenase 2 ( COX-2 ), is indicated for the treatment of acute ...
Leggi articolo
Xagena Search
MedTv
- Antibiotici nel trattamento della Broncopneumopatia Cronica Ostruttiva riacutizzata
- Polmoniti comunitarie - Percorso Diagnostico-Terapeutico
- Terapia Antibiotica per le Infezioni Urinarie Non-Complicate Cistite
- Sinusiti Mascellari Odontogene
- Terapia Antibiotica Empirica
- Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini
- Ruolo della Betaistina nel trattamento di pazienti con sintomi vertiginose
- Cosa fare di fronte al paziente che riferisce vertigini?
- Resistenza batterica agli antibiotici
- Basi per il corretto impiego degli antibiotici in Medicina Generale
MedVideo
- Tumore della tiroide avanzato: trattamento target delle fusioni TRK
- Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini
- Terapie innovative nelle malattie linfoproliferative: update post ASH 2021
- Terapie immunologiche nelle neoplasie mieloidi
- Aggiornamenti da International Myeloma Workshop 2021
- Ruolo dell'immunoterapia nella prima linea di terapia del NSCLC
- Resistenza batterica agli antibiotici
- Basi per il corretto impiego degli antibiotici in Medicina Generale
- Prospettive nella terapia di prima linea del carcinoma polmonare non a piccole cellule non-oncogene-addicted
- Covid-19 e neoplasie ematologiche